MGX
Metagenomi, Inc. Common Stock
NASDAQ: MGX · HEALTHCARE · BIOTECHNOLOGY
$1.38
+2.22% today
Updated 2026-04-30
Market cap
$55.68M
P/E ratio
—
P/S ratio
2.21x
EPS (TTM)
$-2.36
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
4.7
Growth
C5.0
Quality
C+2.5
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$9.33
+576.09%
12-Month target
—
—
Intrinsic (DCF)
$2.87
Margin of safety
+47.04%
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 47.04% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-23.63M
- Revenue declining -59.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $17.20M | $44.76M | $52.30M | $25.21M | $25.21M |
| Net income | $-43.59M | $-68.25M | $-78.06M | $-87.87M | $-22.53M |
| EPS | — | — | — | — | $-2.36 |
| Free cash flow | $15.75M | $-101.22M | $-112.19M | $-89.47M | $-23.63M |
| Profit margin | -253.45% | -152.50% | -149.26% | -348.54% | — |
Peer comparison
Smart narrative
Metagenomi, Inc. Common Stock trades at $1.38. Our Smart Value Score of 29/100 indicates the stock is weak. TTM revenue stands at $25.21M. Our DCF model estimates intrinsic value at $2.87.
Frequently asked questions
What is Metagenomi, Inc. Common Stock's stock price?
Metagenomi, Inc. Common Stock (MGX) trades at $1.38.
Is Metagenomi, Inc. Common Stock overvalued?
Smart Value Score 29/100 (Grade F, Strong Sell). DCF value $2.87.
What is the price target of Metagenomi, Inc. Common Stock (MGX)?
The analyst target price is $9.33, representing +576.1% upside from the current price of $1.38.
What is the intrinsic value of Metagenomi, Inc. Common Stock (MGX)?
Based on our DCF model, intrinsic value is $2.87, a +47.0% margin of safety versus $1.38.
What is Metagenomi, Inc. Common Stock's revenue?
TTM revenue is $25.21M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.21x
ROE-44.70%
Beta0.57
50D MA$1.46
200D MA$1.88
Shares out0.04B
Float0.03B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—